Intelligence Profile
Clinical Applications
Trans-auricular vagus nerve stimulation (taVNS) is a non-invasive therapy under investigation for several clinical applications. Research and trials suggest potential benefits in a range of conditions:
Pain Management: A study published in Nature Communications demonstrated that auricular vagus nerve stimulation provides analgesia in a mouse model of neuropathic pain. This indicates that taVNS could be a valuable tool in pain management strategies.
Post-Stroke Recovery: According to a randomized controlled trial in the American Journal of Physical Medicine & Rehabilitation, taVNS may be beneficial in promoting motor performance and altering biomarkers like interleukin 6 post-stroke, suggesting its role in neurorehabilitation.
Cognitive Function: Research in Physiotherapy Research International shows that taVNS may improve cognitive functions in patients with diabetic polyneuropathy, highlighting its potential in cognitive rehabilitation therapies.
Ongoing Clinical Trials:
- A trial (NCT06095297) is investigating taVNS for cognitive issues related to Long COVID, focusing on brain fog.
- In stroke recovery (NCT06761404), taVNS is being assessed as a non-invasive method to aid recovery, with trials currently recruiting.
- Studies such as NCT07523113 and NCT07646470 are exploring taVNS for cognitive rehabilitation in ME/CFS and its effects in rheumatoid arthritis in asplenic individuals, respectively.
Current evidence supports that taVNS could be beneficial in pain relief, enhancing cognitive functions, and facilitating recovery post-neurological events. However, more clinical data are needed to establish its efficacy across broader populations.
Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice. Always consult a healthcare provider for personalized medical advice.